Groundbreaking clinical trial underway to improve vision in individuals with advanced Retinitis Pigmentosa (RP)

December 15, 2023

https://www.prnewswire.com/news-releases/groundbreaking-clinical-trial-underway-to-improve-vision-in-individuals-with-advanced-retinitis-pigmentosa-rp-301746841.html

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.

MELBOURNE, Australia, Feb. 14, 2023 /PRNewswire/ — In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is proud to announce that dosing has commenced in the Phase 1 first-in-human trial for KIO-301.

Read more at prnewswire.com

Related news for (KPRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.